SUN PHARMACEUTICAL INDUSTRIES INC recalls Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.
Recalled June 14, 2023 · FDA recall D-0869-2023 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
CGMP Deviations · FDA Class II
Units
12,336 bottles
Sold at
Product was distributed to 19 distributors nationwide.
Description
CGMP Deviations
Product
Buprenorphine Sublingual Tablets, 8 mg, 30 count-bottles, Rx only, Manufactured by: Sun Pharma, NDC 62756-460-83.
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →